DraftKings slides as investors weigh legal overhang and earlier cautious 2026 outlook

DraftKings (DKNG) is down 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The day’s pullback looks tied to lingering investor caution after the company’s earlier 2026 guidance reset, with added sensitivity to ongoing legal headlines around past promotional marketing. In the absence of a single fresh company-specific announcement, the move may also reflect profit-taking after recent news-driven swings in the online betting group.

Details:

DraftKings’ Feb. 12, 2026 earnings release introduced fiscal 2026 revenue guidance of $6.5B–$6.9B and adjusted EBITDA guidance of $700M–$900M, which has remained a key narrative driver for the stock’s multiple and near-term sentiment.

DraftKings’ early-March 2026 investor materials highlighted a planned “Super App” approach intended to unify Sportsbook and Casino experiences, a strategy that can spark debate on execution risk and near-term investment levels.

A Massachusetts court has recently allowed a consumer class action tied to a “$1,000 Deposit Bonus” promotion to proceed in parts, keeping legal and reputational risk in the spotlight.

This could be because the stock remains highly reactive to incremental changes in perceived regulatory/legal risk and competitive intensity across U.S. sports betting.

Sources:

DraftKings Investor Relations, Law360, Sports Business Journal

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DKNG Insider Trading Activity

$DKNG insiders have traded $DKNG stock on the open market 16 times in the past 6 months. Of those trades, 3 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $DKNG stock by insiders over the last 6 months:

PAUL LIBERMAN (See Remarks) has made 0 purchases and 2 sales selling 484,417 shares for an estimated $12,187,931.
R STANTON DODGE (Chief Legal Officer) has made 0 purchases and 7 sales selling 211,108 shares for an estimated $6,830,296.
HARRY SLOAN has made 2 purchases buying 125,000 shares for an estimated $2,942,500 and 0 sales.
GREGORY WESTIN WENDT purchased 10,000 shares for an estimated $302,700
ALAN WAYNE ELLINGSON (Chief Financial Officer) sold 8,421 shares for an estimated $246,145
ERIK BRADBURY (Chief Accounting Officer) has made 0 purchases and 3 sales selling 10,151 shares for an estimated $234,330.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DKNG Hedge Fund Activity

We have seen 366 institutional investors add shares of $DKNG stock to their portfolio, and 540 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP removed 19,061,893 shares (-97.5%) from their portfolio in Q4 2025, for an estimated $656,872,832
CAPITAL WORLD INVESTORS added 12,008,357 shares (+181.4%) to their portfolio in Q4 2025, for an estimated $413,807,982
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 11,442,563 shares (-60.7%) from their portfolio in Q4 2025, for an estimated $394,310,720
CITADEL ADVISORS LLC added 9,295,010 shares (+862.7%) to their portfolio in Q4 2025, for an estimated $320,306,044
JANUS HENDERSON GROUP PLC added 8,524,923 shares (+50.8%) to their portfolio in Q4 2025, for an estimated $293,768,846
WHALE ROCK CAPITAL MANAGEMENT LLC removed 5,339,131 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $199,683,499
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 5,092,548 shares (-74.6%) from their portfolio in Q4 2025, for an estimated $175,489,204

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DKNG Analyst Ratings

Wall Street analysts have issued reports on $DKNG in the last several months. We have seen 20 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 01/30/2026
Wells Fargo issued a "Overweight" rating on 01/15/2026
Needham issued a "Buy" rating on 11/19/2025
Mizuho issued a "Outperform" rating on 11/13/2025
Macquarie issued a "Outperform" rating on 11/10/2025
Barclays issued a "Overweight" rating on 11/10/2025
Bernstein issued a "Outperform" rating on 11/10/2025

To track analyst ratings and price targets for $DKNG, check out Quiver Quantitative's $DKNG forecast page.

$DKNG Price Targets

Multiple analysts have issued price targets for $DKNG recently. We have seen 28 analysts offer price targets for $DKNG in the last 6 months, with a median target of $40.0.

Here are some recent targets:

Clark Lampen from BTIG set a target price of $35.0 on 03/03/2026
Chad Beynon from Macquarie set a target price of $40.0 on 03/03/2026
Bernie McTernan from Needham set a target price of $35.0 on 03/03/2026
Jordan Bender from Citizens set a target price of $38.0 on 03/03/2026
Brian Pitz from BMO Capital set a target price of $50.0 on 03/03/2026
Ed Young from Morgan Stanley set a target price of $40.0 on 02/24/2026
Brandt Montour from Barclays set a target price of $37.0 on 02/17/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.